Gulf International Bank (Uk) LTD Gilead Sciences, Inc. Transaction History
Gulf International Bank (Uk) LTD
- $2.9 Billion
- Q1 2025
A detailed history of Gulf International Bank (Uk) LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 71,843 shares of GILD stock, worth $7.95 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
71,843
Previous 97,639
26.42%
Holding current value
$7.95 Million
Previous $9.02 Million
10.73%
% of portfolio
0.28%
Previous 0.23%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
2,289Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.59 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.04 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.93 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $139B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...